tiprankstipranks
Trending News
More News >
Glenmark Pharmaceuticals Limited (IN:GLENMARK)
:GLENMARK
India Market

Glenmark Pharmaceuticals Limited (GLENMARK) Income Statement

Compare
0 Followers

Glenmark Pharmaceuticals Limited Income Statement

Last quarter (Q1 2024), Glenmark Pharmaceuticals Limited's total revenue was ₹32.44B, a decrease of -2.76% from the same quarter last year. In Q1, Glenmark Pharmaceuticals Limited's net income was ₹3.40B. See Glenmark Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
₹ 118.13B₹ 115.83B₹ 121.74B₹ 108.06B₹ 106.57B
Gross Profit
₹ 32.59B₹ 36.30B₹ 41.09B₹ 35.80B₹ 35.42B
Operating Expenses
₹ 46.95B₹ 25.29B₹ 23.57B₹ 19.67B₹ 41.83B
Depreciation and Amortization
₹ 5.82B₹ 6.11B₹ 4.87B₹ 4.44B₹ 4.17B
EBITDA
₹ 11.34B₹ 11.58B₹ 22.26B₹ 21.79B₹ 18.91B
Operating Income
₹ 6.31B₹ 10.79B₹ 18.40B₹ 17.16B₹ 12.82B
Other Income/Expenses
₹ -5.95B₹ -8.39B₹ -3.99B₹ -3.34B₹ -1.86B
Pretax Income
₹ 364.95M₹ 2.40B₹ 14.41B₹ 13.82B₹ 10.96B
Net Income
₹ -15.02B₹ 2.97B₹ 9.42B₹ 9.70B₹ 7.76B
Per Share Metrics
Basic EPS
₹ -53.22₹ 10.53₹ 33.37₹ 34.38₹ 27.50
Diluted EPS
₹ -53.22₹ 10.53₹ 33.37₹ 34.38₹ 27.50
Weighted Average Shares Outstanding
282.16M 282.17M 282.17M 282.17M 282.17M
Weighted Average Shares Outstanding (Diluted)
282.18M 282.17M 282.17M 282.17M 282.17M
Currency in INR

Glenmark Pharmaceuticals Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis